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The gene coding for the aminoglycoside adenylyltransferase (aadA6) from a clinical isolate of Pseudo-
monas aeruginosa was cloned and expressed in Escherichia coli strain BL21(DE3)pLysS. The overexpressed
enzyme (AadA6, 281 amino-acid residues) and a carboxy-terminal truncated variant molecule ([1-264]
AadA6) were puriﬁed to near homogeneity and characterized. Light scattering experiments conducted
under low ionic strength supported equilibrium between monomeric and homodimeric arrangements of
the enzyme subunits. Circular Dichroism spectropolarimetry indicated a close structural relation to
adenylate kinases. Both forms modiﬁed covalently the aminoglycosides streptomycin and spectinomycin.
The enzyme required at least 5 mMMgCl2 for normal Michaelis–Menten kinetics. Streptomycin exhibited
a strong substrate inhibition effect at 1 mM MgCl2. The truncated 17 residues at the C-terminus have
little inﬂuence on protein folding, whereas they have a positive effect on the enzymic activity and sta-
bilize dimers at high protein concentrations (4100 μM). Homology modelling and docking based on
known crystal structures yielded models of the central ternary complex of monomeric AadA6 with ATP
and streptomycin or spectinomycin.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Antibiotic resistance of pathogenic bacteria has received im-
mense attention over the last years as the rapid increase of mul-
tiresistant bacterial strains along with the lack of new antibiotics
became a threat to global public health [1–3]. Aminoglycosides are
a relatively large class of antibiotics that have been employed
extensively over the past decades against aerobic bacterial pa-
thogens [4,5]. They target accessible regions of polyanionic 16S
rRNA on the 30S ribosomal subunit, notably the A site for ami-
noacyl-tRNA binding [6]. Following the discovery of streptomycin
[7] in 1944 aminoglycosides have been widely used due to theirB.V. This is an open access article u
th aminoglycoside adenylyl-
A6 at the carboxy-terminus;
ALS, Multi-angle light scat-
a),
cience, Deutsches Elektronen
Germany.bactericidal action and their observed synergy with other anti-
biotics [8]. Against this class of compounds the bacteria elaborated
three mechanisms of resistance: decreased permeability of the cell
wall [9], ribosome alteration [10] and enzymatic modiﬁcation [11].
The latter mechanism is of most clinical importance as it confers
high level of resistance and the genes encoding aminoglycoside
modifying enzymes can be disseminated by plasmids or transpo-
sons [12]. Aminoglycoside modifying enzymes catalyze the mod-
iﬁcation of hydroxyl or amino groups of 2-deoxystreptamine or
the sugar moieties and can be acetyltransferases (AACs), nucleo-
tidyltranferases (ANTs), or phosphotransferases (APHs) [13]. Evo-
lution by mutagenesis of the genes encoding the aminoglycoside
modifying enzymes led to a high number of variants that can
utilize an ever growing number of aminoglycoside analogues as
substrates. The investigation of the function of such enzymes is
expected to drive the production of efﬁcient inhibitors that can be
used in combination with the known antibiotics to reduce sig-
niﬁcantly infections by resistant pathogens. A streptomycin/spec-
tinomycin adenylyltransferase gene (aadA) was ﬁrst identiﬁed and
sequenced [14] in E. coli and recently the crystal structure of an
aminoglycoside adenylyltransferase (AadA) from Salmonella en-
terica has been determined at 2.5 Å resolution [15]. Herein, wender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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clinical multiresistant isolate of P. aeruginosa Ps100 located in the
integron In118 [16,17]. The protein termed AadA6 belongs to the
subclass of 3″-O-nucleotidyltransferases (ANT3″), it consists of 281
amino-acid residues (UniProt: Q9RGC2) and confers resistance to
streptomycin and spectinomycin [16]. The sequence information
collected from the Conserved Domain Database (CDD) [18] for this
protein points to the conserved nucleotidyltransferase (NTase)
domain lying between residues 10 and 110. This domain includes
the nucleotide triphosphate binding site and one Mg2þ binding
site [19, 20].
In the present work circular dichroism spectra, laser light
scattering and kinetic data have been measured for puriﬁed AadA6
and a C-terminal truncated variant of the enzyme. The latter was
termed [1-264]AadA6 and was produced in an attempt to achieve
an enzyme form easier to crystallize than the wild type. Finally,
two theoretical models of the structures of the AadA6 ternary
complexes with ATP and streptomycin or spectinomycin were built
based on the homologous AadA from S. enterica [15].2. Materials and methods
2.1. Gene cloning
Total DNA from the P. aeruginosa strain Ps100 was puriﬁed by
QIAamp DNA mini kit (Qiagen, Germany) and used in order to
amplify the coding sequence of the aadA6 gene by PCR. The pri-
mers were designed according to sequence information obtained
by direct sequencing of the aadA6 gene containing integron of the
P. aeruginosa strain Ps100 as described previously [21] (GenBank:
AY460181). The PCR products were puriﬁed by the Jetquick kit
(Genomed, Germany) were digested with the NdeI/BamHI en-
donucleases and ligated in the corresponding restriction sites of
the pT7-7 (ampr) expression vector. The recombinant plasmids
were transformed in E. coli BL21(DE3) pLysS cells. Transformed
bacteria were grown in Luria-Bertani (LB) medium containing
100 mg/ml ampicillin and 34 mg/ml chloramphenicol. The site of
insertion of the PCR products was conﬁrmed by Sanger sequencing
of the puriﬁed recombinant plasmids (Macrogen, Europe).
2.2. Protein expression and puriﬁcation
Four liters of LB medium containing 1 mM MgCl2 were in-
oculated with 40 ml of an overnight culture of each of the re-
combinant strains and let grow under shaking at 220 rpm (37 °C).
When the absorbance at 600 nm reached 0.5–0.8 the temperature
was decreased to 18 °C and growth continued for 16 more hours in
the presence of 0.3 mM isopropyl β-D-1-thiogalactopyranoside
(IPTG). 16 g of cell paste was resuspended in 16 ml lysis buffer
(50 mM Tris–HCl pH 7.5, 50 mM NaCl) containing 4 mM mercap-
toethanol and 2 mM MgCl2. Lysozyme was added to 0.3 mg/ml
followed by very gentle stirring on ice for 1.5 h. Following cen-
trifugation the soluble fraction was applied on a 30 ml Q-Sephar-
ose™ matrix (GE Healthcare, Piscataway, NJ, USA). The bound
protein was eluted with a NaCl gradient. Appropriate fractions
were combined and applied on a 20 ml Hydroxyapatite™ matrix
(Bio-Rad Laboratories, Hercules, CA, USA). The bound enzyme was
eluted with a KH2PO4/Na2HPO4 pH 7.2 gradient. Finally, fractions
that eluted with approximately 13 mM KH2PO4/NaHPO4 were ap-
plied on an S-100 Sephacryl HR™ gel ﬁltration column (GE
Healthcare). Samples from all steps of a puriﬁcation experiment
were run with SDS-PAGE. Based on the latter analytical method
selected fractions were combined and concentrated.2.3. In vitro enzymatic activity
Steady-state enzyme kinetics monitored the phosphate as end-
product of the adenylyltransferase action combined with that of
inorganic pyrophosphatase. The analytical method employed was
a modiﬁcation of the colorimetric method based on the reaction of
malachite green, molybdates and phosphates [22,23]. The initial
rates were measured in reaction mixtures of 65 nM enzyme and
varying substrate concentrations in 50 mM Tris–HCl pH 7.5 buffer
containing 15 mM MgCl2 at 23 °C. In the earlier experiments 1,
5 and 10 mM MgCl2 were also present during the kinetic analyses.
Each reaction was stopped at the selected time intervals by addi-
tion of 26 ml 2.25N H2SO4. After standing for 10 min at 0 °C, the
mixture was centrifuged for 3 min in order to remove the protein
and the supernatant was taken for phosphate determination. The
antibiotic substrates spectinomycin and dihydrostreptomycin var-
ied from 2–20 mM. ATP varied from 20–120 and 20–160 mM when
spectinomycin and dihydrostreptomycin were analysed, respec-
tively. Pre-incubation of all reaction components except the ana-
lysed enzyme was performed for 10 min. The latter procedure al-
lowed the consumption of probable endogenous phosphates so
that they did not interfere with the measurements of enzyme
activity. All kinetic data were collected in triplicates. Oxidized
streptomycin was also tested though in a limited number of re-
actions and showed the same kinetic behaviour with its reduced
counterpart.
2.4. Data analysis
Based on earlier results for a closely related enzyme [24] the
same steady-state assumptionwas made for sequential ordered bi-
substrate reactions. In this case, Eq. (1) provides the initial velo-
cities and was ﬁtted with the measured initial rates when both
substrates were varied. Non-linear ﬁts of the data to Eq. (1) were
carried out using Graﬁt 7.0 (Erithacus Software Ltd., Horley, U.K.).
v V K K K KA B / A B A B 1m m mmax ia b b a( )= [ ][ ] + [ ] + [ ] + [ ][ ] ( )
In the above equation, v is the initial velocity, Vmax is the
maximal velocity, Kma and Kmb are the Michaelis–Menten constants
of substrates A and B, respectively and Kia is the dissociation
constant of the ﬁrst substrate A that is added to the enzyme. In the
present analysis, A and B refer to ATP and streptomycin or spec-
tinomycin, respectively.
2.5. Biophysical characterization
Circular Dichroism spectropolarimetry measurements of the
two forms of the puriﬁed enzyme were conducted with a J-810
spectropolarimeter (JASCO, Inc., USA). The data were processed
using both software and reference databases of the DichroWeb
server [25]. For the recording of the spectra protein solutions of
0.2 mg/ml were used in 50 mM potassium phosphate buffer pH
7.5 whereas for the thermal unfolding experiments solutions of
0.1 mg/ml were prepared in the same buffer. During the melting
experiments the ellipticities (θ) at wavelength 209 nm corre-
sponding to the minimum value of the spectra, were recorded
with increasing temperature. CD data for the full-length AadA6
and truncated enzyme [1-264]AadA6 have been deposited in the
Protein Circular Dichroism Data Bank (PCDDB) [26] with PCDDB id
codes: CD0004574000 and CD0004575000, respectively.
The dynamic light scattering [27] of samples containing ap-
proximately 4 mg/ml of enzyme were analysed in 50 mM Tris–HCl
pH 7.5 buffer solutions with two concentrations of MgCl2 (1 and
18 mM for AadA6, 1 and 15 mM for [1-264]AadA6) at 20 °C with
the HELEOS8 MALS (Multi-angle light scattering) instrument
Table 1
Steady-state kinetic parameters of aminoglycoside adenylyltransferase and its en-
gineered variant.
Substrate kcat (s1) Km (μΜ) kcat/Km (Μ1s1)
AadA6 streptomycin 0.6670.06 1.870.6 (3.771.3)105
spectinomycin 0.6370.03 0.470.1 (1.670.4)106
ATP 0.6170.03 11.071.2 (5.570.7)104
[1-264]AadA6 streptomycin 0.4770.04 3.370.7 (1.470.3)105
spectinomycin 0.2670.02 0.270.1 (1.370.7)106
ATP 0.4170.02 10.570.8 (3.970.4)104
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operated in combination with a Superdex 200HR 10/30 pre-
packed gel ﬁltration column (GE Healthcare). The light scattering
experiments were carried out also in the presence of 2 mM of both
AMPCPP and streptomycin. The quasi-elastic scattering data along
with the refractive index and UV absorbance measurements were
analysed with software ASTRAs 6.1.117. This analysis allowed also
the estimation of the molecular masses of the eluates and thus the
assignment of the correct oligomeric state of the protein.
2.6. Homology modelling
A model for the structure of AadA6 (3-262) was obtained from
the Swiss-Model protein server [28] based on the homologous
AadA (identity 45%) from S. enterica (PDB: 4CS6), which served
as template. For this model, a structural alignment of the
N-terminal domain of AadA with chain A of kanamycin nucleoti-
dyltransferase (KNTase) (PDB: 1KNY) was generated, overlapping
mainly the β-strands in this domain. The aim of the latter align-
ment was to locate the ATP and aminoglycoside binding sites. The
structural alignment showed that there are certain characteristic
substrate binding residues in AadA like in KNTase. This allowed
the placement of the substrates ATP and streptomycin to the cor-
responding binding sites in KNTase. Finally, the model was energy
minimized with the program CNS [29] using coordinates and
modiﬁed geometrical restraint ﬁles from the HIC-Up database
(xray.bmc.uu.se/hicup/, [30]). The coordinates of the derived
AadA6 theoretical model are available at the Model Archive (www.
modelarchive.org/) under accession number MA-AWT7Q. In ad-
dition, a second model of AadA6 was derived with ATP and
spectinomycin in the enzyme's active site following analogous
procedures as described above.3. Results
3.1. Strains and antibiotic proﬁle
Clinical strain Ps100 was highly resistant against streptomycin,
gentamycin and amikacin [MIC (Minimum Inhibitory
Concentration) 4256 mg/ml], while the recombinant E. coli strains
expressing either the full length or the truncated AadA6 exhibited
resistance against streptomycin but not gentamycin or amikacin,
indicating that the resistant phenotype was conferred by the
corresponding determinant. The MIC values for streptomycin were
determined by the broth dilution method at 730 and 315 mg/ml for
the E. coli BL21[1-281] and BL21[1-264] strains, respectively. We
assigned the observed differences to the distinct expression levels
(see Section 3.2) and activities (see Section 3.3) of the two
proteins.
3.2. Protein expression and puriﬁcation
On average 16 g of cell pellet yielded about 7 mg of both 95%
pure AadA6 and 98% pure [1-264]AadA6. This was invariably ob-
served despite the approximately half level of expression of [1-
264]AadA6 compared to that of AadA6.
3.3. Enzymatic characterization
AadA6 exhibits high degree of sequence identity (264/268 re-
sidues) to the nucleotidyltransferase domain [ANT(3″)-Ii] of the
bifunctional, nucleotidyl- and acetyl-transferase aminoglycoside
modifying enzyme from Serratia marcescens (UniProt: Q8VQN7),
which has been extensively characterized with regard to its en-
zymatic properties [24]. The high homology between the enzymessuggests that AadA6 acts in a similar fashion. We decided to purify
the truncated form of AadA6 based on the length of the above
mentioned closely related domain of the bifunctional enzyme and
on the results of sequence comparisons with other homologous
proteins [31] using the Universal Protein Resource Knowledgebase.
Enzymatic assays of product inorganic pyrophosphate using
streptomycin as substrate provided speciﬁc activities of 1.370.1
and 0.970.1 mmol min1 mg1 for homogeneous samples of
AadA6 and [1-264]AadA6, respectively. The latter values indicate
that the truncated enzyme is about 70% as active as the original
full-length enzyme in vitro. The observed decrease of activity is
due to the truncation of the 17C-terminal residues. The active site
comprises mainly N-terminal residues according to the theoretical
models described below (Section 3.5). The determined kinetic
parameters for AadA6 are summarized in Table 1. These results
agree to the earlier reported values for the bifunctional enzyme
[24] except of the Km value for spectinomycin, which was calcu-
lated to be about four times lower. This leads to a ﬁve-fold higher
speciﬁcity of AadA6 for spectinomycin comparing to the highly
homologous enzyme from S. marcescens.
Moreover, kanamycin A, gentamycin, and amikacin were also
tested as substrates for AadA6 with no detectable rates of reaction.
Kanamycin Awas actually found to be competitive inhibitor for the
aminoglycoside substrates.
Finally, it is worth noting that when the initial velocity mea-
surements were carried out in the presence of 1 mM MgCl2 a
strong substrate inhibition effect was invariably observed by
streptomycin. This was largely alleviated by increasing the con-
centration of MgCl2 to 5 mM. An analogous Mg2þ concentration
effect was also observed in the case of kanamycin nucleotidyl-
transferase [32] as well as other aminoglycoside adenylyl-
transferases [33].
3.4. Biophysical characterization
Analysis of the far-UV (190–240 nm) CD-spectra shown in
Fig. 1A provided for AadA6 58% α-helical and 19% β-sheet content.
The respective values for [1-264]AadA6 were 52% and 23%. The CD
spectra of AadA6 revealed remarkable similarity to that of ade-
nylate kinase (PDB: 3ADK), which is used in various reference data
sets for the estimation of secondary structure by CD spectroscopy.
In order to probe the thermal denaturation of both forms of the
enzyme, CD measurements were conducted as function of tem-
perature (Fig. 1B). The melting temperatures (Tm) for AadA6 and
[1-264]AadA6 were estimated by interpolation on the melting
curves as 49.5 and 51.070.5 °C, respectively. The thermal un-
foldings of the full-length and truncated enzymes were found to
occur in one irreversible step.
In addition, laser light scattering experiments were carried out
for both AadA6 and [1-264]AadA6 in combination with an analy-
tical gel ﬁltration column. The results of two selected experiments
are shown in Fig. 2 and a complete list of the derived molecular
hydrodynamic radii is given in Table 2.
All light scattering measurements support equilibrium between
Fig. 1. Circular Dichroism spectropolarimetry data and thermal denaturation
curves. (A) Far-UV CD spectra of AadA6 (red) and [1-264]AadA6 (blue) were re-
corded at 10 °C. (B) Superimposed thermal melting CD curves for both proteins are
labelled as in (A). The ordinates of both plots present values of mean residue el-
lipticity [θ].
Fig. 2. Multi-angle light scattering (MALS) curves. Relative quasi-elastic light
scattering intensities (right axis) of AadA6 (red) and [1-264]AadA6 (blue) in 50 mM
Tris–HCl pH 7.5 buffer at 1 mM MgCl2 as function of their elution volumes from an
analytical gel-ﬁltration column. The two peaks correspond to the dimer and
monomer of each protein. The estimates of the respective molecular hydrodynamic
radii (RH) as function of volume slice are also shown. The plots were produced by
the data analysis software provided by the instrument manufacturer.
Table 2
Average hydrodynamic radii (RH) of AadA6 and [1-264]AadA6 based on multi-angle
light scattering experiments.
AadA6 AMPCPPa Streptomycina Dimer Monomer
RH (nm) RH (nm)
1 mΜ MgCl2 3.470.1 2.270.2
þ þ 3.3 2.0
18 mΜ MgCl2 2.9 1.9
þ þ 3.3 1.5
[1-264] AadA6
1 mΜ MgCl2 3.370.1 2.470.1
þ þ 3.4 2.4
15 mΜ MgCl2 3.2 2.5
þ þ 3.0 2.4
a AMPCPP and streptomycin were added each at 2 mM concentrations.
M. Papadovasilaki et al. / Biochemistry and Biophysics Reports 4 (2015) 152–157 155dimeric and monomeric species of AadA6, with mean hydro-
dynamic radii of 3.470.1 and 2.270.2 nm, respectively. The same
holds true for [1-264]AadA6 with respective values 3.370.1 and2.470.1 nm. Addition of MgCl2 and substrate or substrate analo-
gues led to a decrease of the apparent size of the proteins. The
latter effect was more prominent for the monomeric form of
AadA6. MALS data collected from solutions with ionic strength
values of 60–150 mM showed that AadA6 is in equilibriumwith an
approximate 1:1 dimer to monomer ratio whereas the corre-
sponding value for [1-264]AadA6 was about 1:4. This latter ob-
servation indicates that the deleted C-terminal residues favour the
formation of protein dimers at concentrations approximately
100 μΜ used in these light scattering experiments. The occur-
rence of monomers is in agreement with the recently reported
structure of AadA from S. enterica [15].
Moreover, the ionic strength seems to inﬂuence the dimeriza-
tion of the molecule. Light scattering experiments of 400 mM [1-
264]AadA6 in high ionic strength solutions (350 mM) showed
that the protein is dimeric (data not shown). This ﬁnding is in
agreement with the reported structures of the distantly related
(identity o20%) kanamycin nucleotidyltransferase [20] from S.
aureus (PDB: 1KNY) and aminoglycoside 4′-O-adenylyltransferase
[ANT(4′)-IIb] from P. aeruginosa (PDB: 4EBJ).
3.5. Homology modelling
Two theoretical models were constructed for the structures of
AadA6 with ATP and streptomycin or spectinomycin. Both com-
prise two structural domains that are in the ‘closed’ state similar to
the starting model (PDB: 4CS6) and different to the kanamycin
nucleotidyltransferase (KNTase) structure. In the latter case an
‘open’ state of the domains was reported, which facilitates the
formation of the observed dimers in the KNTase structure. First,
the bound substrates ATP and streptomycin were also modelled
based on the structure of the KNTase ternary complex with
AMPCPP and kanamycin. Second, a model was obtained for the
ternary complex of AadA6:ATP:Spectinomycin. A close-up view of
the modelled active site region of the ﬁrst structure with both
substrates bound is shown in Fig. 3. In the latter ﬁgure are shown
most of the interactions except those between the bound ATP and
Ser46, Asp130 and Tyr231. There are three H-bonds between
streptomycin and the enzyme. There was also found one H-bond
between ATP and streptomycin. Residues of the N-terminal do-
main (1-157) constitute mainly the active site of the enzyme. The
C-terminal domain contributes only three residues when strep-
tomycin was modelled, namely Asn185 that H-bonds to strepto-
mycin and Lys205, Tyr231 that H-bond to ATP. Fig. S1 of the
Supplementary section shows a close-up view of the second
modelled structure in an analogous content and orientation. In
this Figure the two additional H-bonds of spectinomycin with the
enzyme are shown, namely those with Gln108 and Asp182. This
additional interaction may provide an explanation for the higher
speciﬁcity of AadA6 for spectinomycin.
Fig. 3. Theoretical modelling of AadA6 structure. Active site view with both ATP
and streptomycin. The crystal structures used as templates were, AadA from S.
enterica (PDB: 4CS6) and kanamycin nucleotidyltransferase from S. aureus (PDB:
1KNY). The labelled protein residues that interact with the substrates are shown in
stick representation (atom colours, carbon: yellow for streptomycin and light yel-
low for ATP, nitrogen: blue, oxygen: red, phosphorus: orange). The sphere in ma-
genta denotes the magnesium ion. The dashes indicate H-bonding or the co-ordi-
nation of the magnesium ion. The ﬁgure was prepared with PyMOL (http://www.
pymol.org).
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The enzyme kinetic experiments presented in this work for
AadA6 from P. aeruginosa and its truncated variant [1-264]AadA6
revealed clear and measurable deviation of the catalytic activity
between the two forms. AadA6 was found to be about 40% more
active than [1-264]AadA6 in modifying streptomycin indicating
that the 17 residues at the C-terminus, which are missing in [1-
264]AadA6 are necessary for full activity. The same 17C-terminal
residues also support protein dimerization at high enzyme con-
centrations (4100 μM) as is derived from MALS experiments
contacted under ionic strength conditions (60–150 and 350 mM)
close to the physiological values (4100 mM) [34]. Moreover,
AadA6 exhibits higher speciﬁcity for spectinomycin, which is re-
tained in the truncated form. The higher speciﬁcity for spectino-
mycin compared to streptomycin may be explained theoretically
as follows. The model derived for the structure of the complex of
AadA6 with ATP and spectinomycin shows ﬁve H-bonds between
the enzyme and the antibiotic whereas the respective H-bonds
with streptomycin are only three. This leads to a better binding of
spectinomycin compared with streptomycin and thus higher spe-
ciﬁcity for spectinomycin. In the presence of 1 mM MgCl2 used in
the early experiments a prominent substrate inhibition was ob-
served with streptomycin for concentrations greater than 3 mM. It
is noteworthy that this MgCl2 concentration lies close to the re-
ported physiological values of uncomplexed, free magnesium ions
(0.9–1.5 mM) for the S. enterica [35]. Substrate inhibition as well as
the decrease of the protein size observed with the MALS experi-
ments may be due to a more general binding of Mg2þ with this
acidic enzyme (theoretical pI 5.0). Non-speciﬁc Mg2þ binding
may eliminate a potential non-productive binding of streptomycin
to the negatively charged pocket of the active site [15] leading thus
to the observed normal Michaelis–Menten kinetics. Furthermore,
partial neutralization of the negative charges on the protein sur-
face could result in a more compactly folded structure with the
observed smaller hydrodynamic radius. Further work is necessary
for the elucidation of the general effect of magnesium ions. This
will provide a thorough explanation of the phenomenon and help
towards the rational design of AadA6 inhibitors.
The determined kinetic parameters are in agreement with the
results for the closely related nucleotidyltransferase domain of the
bifunctional enzyme from S. marcescens [24]. The only notable
difference is the speciﬁcity constant for spectinomycin, which forAadA6 was about ﬁve times greater. The authors cannot provide a
plausible explanation for this observation due to the absence of
any structures for the bifunctional enzyme.
In the proposed model of the ternary complex with ATP and
streptomycin the distance of the 3″-O of streptomycin is about 6 Å
from the α-phosphorus (Pα) of ATP (Fig. 3). This structure after re-
arrangement could lead eventually to a nucleophilic attack on the
Pα of ATP resulting in the transfer of its adenyl moiety to the 3″-
hydroxyl group of streptomycin. The reaction may be facilitated by
the nearby residue Glu87 acting as catalytic base. Analogous ar-
guments hold true for spectinomycin although its oxygen O-9
subject to adenylation is modelled even further away (6.8 Å) from
the α-phosphorus of ATP. The proposed models show the potential
rearrangement of the ternary complexes and give insight on the
catalytic activity of AadA6. This latter activity is required for the
herein presented kinetic experiments at a low enzyme con-
centration (65 nM), which justiﬁes for the exclusive presence of
the monomeric form. A different arrangement of the substrates
may be possible on two cooperating active sites in case the en-
zyme is to function as dimer.
Sequence comparisons suggest that AadA6 belongs to the su-
perfamily of ancient nucleotidyltransferases involved in diverse
biological functions that range from DNA repair to regulation of
biosynthetic pathways and antibiotic resistance [36]. Detailed
structure comparisons with members of this superfamily have to
wait for the determination of the three-dimensional structure of
AadA6 under various conditions.
Finally, the herein described biochemical and biophysical
properties along with the supplied structural models provide in-
sight for substrate binding with AadA6 and may facilitate future
attempts to design inhibitors that will allow the re-usage of the
ﬁrst generation antibiotics like the aminoglycosides against mul-
tiresistant pathogens.5. Note
This paper is dedicated to the memory of our late colleague Dr.
Yannis Papanikolau who had generously advised us on the protein
puriﬁcation procedures.Acknowledgements
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